Scientists make breakthrough in Alzheimer’s research

SCIENTISTS believe they have made an important breakthrough in developing treatments for Alzheimer’s disease. Results of trials on a new drug suggest it can slow the pace of the condition’s progress.
Information released by the drug company Eli Lilly points to their drug, solanezumab, reducing the speed of mental decline by about a third, and it seems the drug may be able to keep brain cells killed by the condition alive for longer.
The scientific community has extended a cautious welcome to the news, presented at an American conference, although data is still limited. Significant to the research was the stage at which the drug was given, with best effects registered in those who received the treatment early.